Stock Plans and Share-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Shares Authorized, Available for Future Grant and Outstanding Under Each Plans |
The following table presents shares authorized, available for future grant and outstanding under each of our plans as of December 31, 2025 (in millions): | | | | | | | | | | | | | | | | | | | Authorized | | Available (1) | | Outstanding | | | | | | | | | | | | | | | | | | | | | | 2022 Incentive Plan | 33.4 | | | 16.4 | | | 5.8 | | | Topgolf Equity Compensation Plans and Option Agreement | 2.7 | | | — | | | 0.5 | | | Total | 36.1 | | | 16.4 | | | 6.3 | | | | | | | | (1) Includes shares subject to a full award value under the 2022 Incentive Plan’s fungible share ratio. PRSUs are counted against the share reserve based on “maximum” level of performance and may vest up to 200% of the “target” number of units, depending on the year granted and the terms of such awards. |
|
| Schedule of Stock Option Activities |
The following table summarizes our stock option activities for the year ended December 31, 2025 (in millions, except per share amounts and contractual term): | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options | | Number of
Shares | | Weighted-
Average
Exercise Price
Per Share | | Weighted-
Average
Remaining
Contractual
Term | | Aggregate
Intrinsic
Value | | Outstanding at January 1, 2025 | | 0.6 | | | $ | 29.44 | | | | | | | | | | | | | | | Exercised (1) | | — | | | $ | 9.37 | | | | | | | | | | | | | | | | Expired | | (0.1) | | | $ | 20.48 | | | | | | | Outstanding at December 31, 2025 | | 0.5 | | | $ | 30.82 | | | 2.4 | | $ | — | | | Vested and expected to vest in the future at December 31, 2025 | | 0.5 | | | $ | 30.82 | | | 2.4 | | $ | — | | | Exercisable at December 31, 2025 | | 0.5 | | | $ | 30.82 | | | 2.4 | | $ | — | | | | | | | | | | | (1) A nominal number of stock options were exercised during the year ended December 31, 2025. |
|
| Schedule of Intrinsic Value and Cash Received for Option Exercises |
The following table summarizes information related to intrinsic value and cash received related to option exercises for the periods presented below (in millions): | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | 2025 | | 2024 | | 2023 | Intrinsic value for options exercised (1) | $ | — | | | $ | — | | | $ | 1.7 | | Cash received from exercise of options (1) | $ | 0.1 | | | $ | 0.1 | | | $ | 4.2 | | | | | | | | (1) Intrinsic value and cash received related to option exercises were nominal during the years ended December 31, 2025 and 2024. |
|
| Schedule of Roll-Forward of Activity for Restricted Stock Units |
The following table represents activity for restricted stock units, restricted stock awards, and performance-based awards for the year ended December 31, 2025 (in millions, except fair value amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | | RSAs | | PRSUs | | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | Unvested at January 1, 2025 | | 1.7 | | | $ | 16.81 | | | — | | | $ | — | | | 2.3 | | | $ | 27.85 | | | Granted | | 2.9 | | | $ | 6.86 | | | — | | | $ | — | | | 1.7 | | | $ | 8.57 | | | Vested | | (0.9) | | | $ | 17.14 | | | — | | | $ | — | | | (0.5) | | | $ | 29.52 | | | | | | | | | | | | | | | Forfeited | | (0.5) | | | $ | 9.52 | | | — | | | $ | — | | | (0.9) | | | $ | 23.85 | | | | | | | | | | | | | | | Unvested at December 31, 2025 | | 3.2 | | | $ | 8.88 | | | — | | | $ | — | | | 2.6 | | | $ | 16.20 | | | | | | | | | | | | | | | | |
|
| Schedule of Roll-Forward of Activity for Restricted Stock |
The following table represents activity for restricted stock units, restricted stock awards, and performance-based awards for the year ended December 31, 2025 (in millions, except fair value amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | | RSAs | | PRSUs | | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | Unvested at January 1, 2025 | | 1.7 | | | $ | 16.81 | | | — | | | $ | — | | | 2.3 | | | $ | 27.85 | | | Granted | | 2.9 | | | $ | 6.86 | | | — | | | $ | — | | | 1.7 | | | $ | 8.57 | | | Vested | | (0.9) | | | $ | 17.14 | | | — | | | $ | — | | | (0.5) | | | $ | 29.52 | | | | | | | | | | | | | | | Forfeited | | (0.5) | | | $ | 9.52 | | | — | | | $ | — | | | (0.9) | | | $ | 23.85 | | | | | | | | | | | | | | | Unvested at December 31, 2025 | | 3.2 | | | $ | 8.88 | | | — | | | $ | — | | | 2.6 | | | $ | 16.20 | | | | | | | | | | | | | | | | |
|
| Schedule of Roll-Forward of Activity for Performance Shares |
The following table represents activity for restricted stock units, restricted stock awards, and performance-based awards for the year ended December 31, 2025 (in millions, except fair value amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | | RSAs | | PRSUs | | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | | Units | | Weighted-
Average
Grant-Date
Fair Value | Unvested at January 1, 2025 | | 1.7 | | | $ | 16.81 | | | — | | | $ | — | | | 2.3 | | | $ | 27.85 | | | Granted | | 2.9 | | | $ | 6.86 | | | — | | | $ | — | | | 1.7 | | | $ | 8.57 | | | Vested | | (0.9) | | | $ | 17.14 | | | — | | | $ | — | | | (0.5) | | | $ | 29.52 | | | | | | | | | | | | | | | Forfeited | | (0.5) | | | $ | 9.52 | | | — | | | $ | — | | | (0.9) | | | $ | 23.85 | | | | | | | | | | | | | | | Unvested at December 31, 2025 | | 3.2 | | | $ | 8.88 | | | — | | | $ | — | | | 2.6 | | | $ | 16.20 | | | | | | | | | | | | | | | | |
|
| Schedule of Fair Value of Awards Vested and Weighted Average Grant Date Fair Value per Share |
The following table summarizes fair value of awards vested and the weighted-average grant date fair value per share of awards granted during the periods presented below (in millions, except for per share amounts): | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2025 | | 2024 | | 2023 | | RSUs: | | | | | | | Total fair value of RSUs vested | $ | 14.8 | | | $ | 19.1 | | | $ | 17.3 | | | Per share weighted-average grant date fair value of RSU grants | $ | 6.86 | | | $ | 13.25 | | | $ | 22.78 | | | | | | | | | RSAs: | | | | | | | Total fair value of RSAs vested | $ | — | | | $ | 0.5 | | | $ | 1.3 | | Per share weighted-average grant date fair value of RSA grants (1) | $ | — | | | $ | — | | | $ | 19.60 | | | | | | | | | PRSUs: | | | | | | | Total fair value of PRSUs vested | $ | 13.7 | | | $ | 40.8 | | | $ | 7.8 | | | Per share weighted-average grant date fair value of PRSU grants | $ | 8.57 | | | $ | 19.01 | | | $ | 36.58 | | | | | | | | (1) There were no RSAs granted during the years ended December 31, 2025 and 2024. |
|
| Schedule of Share-Based Payment Arrangement, Nonvested Award, Cost Not Yet Recognized |
The following table summarizes the unamortized compensation expense, net of estimated forfeitures, of awards granted under our share-based plans as of December 31, 2025, as well as their related weighted-average remaining recognition period (in millions, except for periods): | | | | | | | December 31, 2025 | | RSUs: | | | Unamortized compensation expense for RSUs | $ | 15.8 | | | Weighted-average remaining recognition period (in years) | 1.8 | | | | | | | | | | | | PRSUs: | | | Unamortized compensation expense for PRSUs | $ | 13.4 | | | Weighted-average remaining recognition period (in years) | 1.6 |
|
| Schedule of Share-Based Compensation Including Expense for Phantom Stock Units and Cash Settled Stock Appreciation Rights Granted to Employees |
The table below summarizes amounts recognized for share-based compensation by award-type, net of estimated forfeitures, in our consolidated statement of operations for the periods presented (in millions): | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2025 | | 2024 | | 2023 | | | | | | | | Restricted stock units | $ | 10.2 | | | $ | 9.8 | | | $ | 11.8 | | | | | | | | | Performance based restricted share unit awards | 13.6 | | | 17.8 | | | 21.5 | | | | | | | | | Total share-based compensation expense, before tax | 23.8 | | | 27.6 | | | 33.3 | | | Income tax benefit | (5.7) | | | (6.6) | | | (8.0) | | | Total share-based compensation expense, after tax | $ | 18.1 | | | $ | 21.0 | | | $ | 25.3 | |
The table below summarizes amounts recognized for share-based compensation, net of estimated forfeitures, in our consolidated statement of operations for the periods presented (in millions): | | | | | | | | | | | | | | | | | | | Years Ended December 31, | | 2025 | | 2024 | | 2023 | | Cost of sales | $ | 1.6 | | | $ | 1.6 | | | $ | 2.4 | | | Selling, general and administrative expenses | 21.8 | | | 25.5 | | | 30.7 | | | Research and development expenses | 0.4 | | | 0.5 | | | 0.2 | | | Share-based compensation expense, before tax | 23.8 | | | 27.6 | | | 33.3 | | | Income tax benefit | (5.7) | | | (6.6) | | | (8.0) | | | Share-based compensation expense, after tax | $ | 18.1 | | | $ | 21.0 | | | $ | 25.3 | |
|